Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

1-O-Acetyl-2,3,5-tri-O-benzoyl-ß-D-ribofuranose

1-O-Acetyl-2,3,5-tri-O-benzoyl-ß-D-ribofuranose is listed in the pharmaceutical impurity collection under CAS 6974-32-9. Its represented structure has formula C28H24O9 and a calculated molecular weight of 504.49 g/mol.

2D chemical structure

O O O O O O O O O ( S ) ( R ) ( R ) ( R )

Chemical identity

Catalog name
1-O-Acetyl-2,3,5-tri-O-benzoyl-ß-D-ribofuranose
Common name
1-O-Acetyl-2,3,5-tri-O-benzoyl-ß-D-ribofuranose
Chemical name
[(2R,3R,4R,5S)-5-acetyloxy-3,4-dibenzoyloxyoxolan-2-yl]methyl benzoate
CAS
6974-32-9
SMILES
CC(=O)O[C@@H]1O[C@H](COC(=O)c2ccccc2)[C@@H](OC(=O)c2ccccc2)[C@H]1OC(=O)c1ccccc1
InChI
InChI=1S/C28H24O9/c1-18(29)34-28-24(37-27(32)21-15-9-4-10-16-21)23(36-26(31)20-13-7-3-8-14-20)22(35-28)17-33-25(30)19-11-5-2-6-12-19/h2-16,22-24,28H,17H2,1H3/t22-,23-,24-,28-/m1/s1
InChIKey
GCZABPLTDYVJMP-CBUXHAPBSA-N
Associated API
Azacitidine

Record ID: A4b491b307f24

Computed properties

C28H24O9 Molecular formula
504.491 g/molMolecular weight
504.142 DaMonoisotopic exact mass
114.43 ŲTopological polar surface area
3.5826 Calculated LogP (Wildman–Crippen)
128.4425 cm³/molMolar refractivity (Wildman–Crippen)
9 countHydrogen-bond acceptors
0 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 3 6 9 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C H O 0 6 12 18 24 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight504.49185.49
Calculated LogP (Wildman–Crippen)3.582672.14
Topological polar surface area114.4379.44
Hydrogen-bond acceptors991.13
Hydrogen-bond donors011.28
Rotatable bonds (strict)882.26

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC28H24O9dimensionless
Molecular weight504.491g/mol
Monoisotopic exact mass504.142Da
Topological polar surface area114.43Ų
Calculated LogP (Wildman–Crippen)3.5826dimensionless
Molar refractivity (Wildman–Crippen)128.4425cm³/mol
Hydrogen-bond acceptors9count
Hydrogen-bond donors0count
Rotatable bonds (strict)8count
Heavy atoms37count
Heteroatoms9count
Rings4count
Aromatic rings3count
Aliphatic rings1count
Saturated rings1count
Aromatic heterocycles0count
Aliphatic heterocycles1count
Saturated heterocycles1count
Aromatic carbocycles3count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.2143fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters4count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area212.403Ų
Valence electrons190count
Radical electrons0count
Bertz complexity1,228.2821index
Balaban J1.5842index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for 1-O-Acetyl-2,3,5-tri-O-benzoyl-ß-D-ribofuranose

Qualification and safety assessment of 1-O-Acetyl-2,3,5-tri-O-benzoyl-ß-D-ribofuranose

Explore toxicological qualification of 1-O-Acetyl-2,3,5-tri-O-benzoyl-ß-D-ribofuranose and ICH M7 mutagenic impurity assessment of 1-O-Acetyl-2,3,5-tri-O-benzoyl-ß-D-ribofuranose for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for 1-O-Acetyl-2,3,5-tri-O-benzoyl-ß-D-ribofuranose and acceptable intake and limit justification for 1-O-Acetyl-2,3,5-tri-O-benzoyl-ß-D-ribofuranose. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Other catalogue designations with the same represented structure

These are separate catalogue entries; shared structure does not establish interchangeable pharmacopoeial designations.

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for 1-O-Acetyl-2,3,5-tri-O-benzoyl-ß-D-ribofuranose

Explore Altox services and software through the Altox Pharma-Hub.